Comunicados de prensa MHRA — Medicines and Healthcare products Regulatory Agency — Feed RSS y monitoreo en vivo
PPN World sigue el feed RSS de MHRA — Medicines and Healthcare products Regulatory Agency en tiempo real — 7 comunicados indexados en los últimos 30 días, el más reciente llegó hace 1 d. Síguelo con alertas de búsquedas guardadas, resúmenes con IA y búsqueda de texto completo.
Correo diario gratuito
Lo que llega mañana
Los grandes eventos mundiales de mañana, de la agenda de PPN World (bancos centrales, datos, elecciones, cumbres), cada tarde a las 17:00 UTC.
Un correo al día. Sin cuenta. Baja con un clic.
Sobre este feed
MHRA — Medicines and Healthcare products Regulatory Agency forma parte de los más de 1,400 feeds de comunicados que PPN World monitorea de forma continua — una fuente en inglés centrada en el sector Salud y ciencias de la vida, clasificada bajo «Reino Unido» en nuestro índice por país. Cada comunicado se deduplica, se geolocaliza y se enriquece con un resumen de IA, y puedes añadir alertas de búsquedas guardadas sobre cualquier palabra clave que publique. MHRA — Medicines and Healthcare products Regulatory Agency es una fuente especializada de bajo volumen — 7 comunicados en los últimos 30 días: el tipo de fuente que merece una alerta más que un desplazamiento.
Sigue MHRA — Medicines and Healthcare products Regulatory Agency en tiempo real en PPN World
Cada comunicado de MHRA — Medicines and Healthcare products Regulatory Agency llega al cockpit segundos después de publicarse — deduplicado, clasificado, con alertas de búsquedas guardadas y resúmenes con IA, junto a más de 1,400 feeds.
Crear cuenta gratis →Últimos comunicados de MHRA — Medicines and Healthcare products Regulatory Agency
- MHRA appoints senior NHS executive as new Chief Finance and Commercial Officerhace 1 d
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed a new Chief Financial and Commercial Officer to drive forward the financial aspects of its new five-year strategy.
- Government backs modernisation of gene therapy definitionshace 1 d
Proposed changes will provide clearer regulatory pathway for certain synthetic gene therapies, supporting life sciences innovation while maintaining safety.
- New MHRA service to support medicines innovation and strengthen UK manufacturinghace 2 d
AdvanceGxP will give developers earlier practical support for advanced manufacturing technologies, accelerating patient access to innovative medicines while strengthening UK manufacturing.
- MHRA launches new programme to tackle evidence gaps on women’s healthhace 4 d
Women’s Health Programme aims to support innovation in women’s health and better understand how the risks and benefits of medicines and medical devices may differ for women.
- MHRA: services during Microsoft outagehace 7 d
We have been experiencing problems sending and receiving emails.
- MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancerhace 9 d
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved retifanlimab (ZYNYZ) for the treatment of adults with squamous cell carcinoma of the anal canal (SCAC).
- Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathwayhace 11 d
Three innovative medicines with the potential to meet unmet needs in lung cancer, Huntington’s disease and Alzheimer’s disease have been given Innovation Passports, the Medicines and Healthcare produc…
- MHRA sets out approach to strengthen patient and public involvement and engagement in medicines and medical device regulationhace 15 d
New plan will broaden participation and make clearer how patient experience informs regulatory decisions, safety and innovation
- MHRA guidance on its assessment of non-clinical data generated outside OECD systemhace 16 d
MHRA issues new guidance on its approach to clinical trial applications that rely on non-clinical safety data generated outside the OECD Mutual Acceptance of Data system.
- Clinical trials for medicines: Inclusion and Diversity Plan pilot findings publishedhace 17 d
The Health Research Authority (HRA) has published the findings from its pilot on researchers and sponsors of clinical trials and clinical investigations developing and submitting an Inclusion and Dive…
- MHRA launches patient safety essay competition for MedSafetyWeekhace 18 d
The MHRA reminds patients, parents, carers and healthcare professionals to report suspected side effects through the Yellow Card scheme for MedSafetyWeek 2026.
- Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disordershace 21 d
MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.
Los comunicados más recientes de esta fuente se transmiten en vivo para los miembros de PPN World.